Serum immunoglobulin levels in patients with neuroblastoma and their prognosis.
D000293:Adolescent; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001609:Beta-Globulins / Q000378:metabolism; D002648:Child; D002675:Child, Preschool; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000378:metabolism; D007074:Immunoglobulin G / Q000378:metabolism; D007075:Immunoglobulin M / Q000378:metabolism; D007136:Immunoglobulins / Q000378:metabolism*; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009447:Neuroblastoma / Q000276:immunology* / Q000628:therapy; D011379:Prognosis
D000970:Antineoplastic Agents; D001609:Beta-Globulins; D003037:Cobalt Radioisotopes; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins